Mechanism of atopic cataract caused by eosinophil granule major basic protein

Uehara M, Amemiya T, Arai M (1985) Atopic cataracts in a Japanese population. With special reference to factors possibly relevant to cataract formation. Dermatologica 170:180–184 Taniguchi H, Ohki O, Yokozeki H, Katayama I, Tanaka A, Kiyosawa M, Nishioka K (1999) Cataract and retinal detachment in patients with severe atopic dermatitis who were withdrawn from the use of topical corticosteroid. J Dermatol 26:658–665 Andogsky NL (1914) Cataracta dermatogenes: ein beitragzur aetiologie der linsentrubung. Klin Monatsbl Augenheilkd 17:824–831 Hida T, Tano Y, Okinami S, Ogino N, Inoue M (2000) Multicenter retrospective study of retinal detachment associated with atopic dermatitis. Jpn J Ophthalmol 44:407–418 Jeon HS, Choi M, Byun SJ, Hyon JY, Park KH, Park SJ (2018) Association of pediatric atopic dermatitis and cataract development and surgery. JAMA Ophthalmol 136:912–918 Karel I, Myska V, Kvícalová E (1965) Ophthalmological changes in atopic dermatitis. Acta Derm Venereol 45:381–386 Amemiya T, Matsuda H, Uehara M (1980) Ocular findings in atopic dermatitis with special reference to the clinical features of atopic cataract. Ophthalmologica 180:129–132 Christensen JD (1981) Frequency of cataract in atopic dermatitis. Acta Derm Venereol 61:76–77 Kaujalgi R, Handa S, Jain A, Kanwar AJ (2009) Ocular abnormalities in atopic dermatitis in Indian patients. Indian J Dermatol Venereol Leprol 75:148–151 Carmi E, Defossez-Tribout C, Ganry O, Cene S, Tramier B, Milazzo S, Lok C (2006) Ocular complications of atopic dermatitis in children. Acta Derm Venereol 86:515–517 Garrity JA, Liesegang TJ (1984) Ocular complications of atopic dermatitis. Can J Ophthalmol 19:21–24 Furue M, Chiba T, Takeuchi S (2011) Current status of atopic dermatitis in Japan. Asia Pac Allergy 1:64–72 Cordes FC, Cordero-Moreno R (1946) Atopic cataracts. Report of four cases. Am J Ophthalmol 29:402–407 Kadoya K, Ogino T, Sato Y, Tanaka Y, Shoji E, Chikuda M, Obara Y (1996) Immunological and biochemical analysis of atopic cataract. Atarashii Ganka 13:1723–1727 (in Japanese) Luo W, Xu W, Xia L, Xie D, Wang L, Guo Z, Cheng Y, Liu Y, Li W (2017) Family-based whole exome sequencing of atopic dermatitis complicated with cataracts. Oncotarget 8:59446–59454 Haeck IM, Rouwen TJ, Timmer-de Mik L, de Bruin-Weller MS, Bruijnzeel-Koomen CA (2011) Topical corticosteroids in atopic dermatitis and the risk of glaucoma and cataracts. J Am Acad Dermatol 64:275–281 Castrow FF 2nd (1981) Atopic cataracts versus steroid cataracts. J Am Acad Dermatol 5:64–66 Ayaki M, Ohoguro N, Azuma N, Majima Y, Yata K, Ibaraki N, Singh DP, Ko V, Shinohara T (2002) Detection of cytotoxic anti-LEDGF autoantibodies in atopic dermatitis. Autoimmunity 35:319–327 Hori K, Matsuda A, Ebihara N, Imai K, Mori K, Funaki T, Watanabe Y, Nakatani S, Okada K, Matsuo O, Murakami A (2012) Involvement of plasminogen activator inhibitor-1 in the pathogenesis of atopic cataracts. Invest Ophthalmol Vis Sci 53:1846–1851 Yokoi N, Hirano S, Okamoto S, Matsumoto Y, Yokoi K, Ikeda T, Kinoshita S, Katoh N, Yasuno H (1996) Association of eosinophil granule major basic protein with atopic cataract. Am J Ophthalmol 122:825–829 Hamann KJ, Barker RL, Ten RM, Gleich GJ (1991) The molecular biology of eosinophil granule proteins. Int Arch Allergy Appl Immunol 94:202–209 Kapp A (1993) The role of eosinophils in the pathogenesis of atopic dermatitis-eosinophil granule proteins as markers of disease activity. Allergy 48:1–5 Wardlaw AJ (1990s) Eosinophils in the 1990s: new perspectives on their role in health and disease. Postgrad Med 70:536–552 Plager DA, Adolphson CR, Gleich GJ (2001) A novel human homolog of eosinophil major basic protein. Immunol Rev 179:192–202 Trocme SD, Kephart GM, Allansmith MR, Bourne WM, Gleich GJ (1989) Conjunctival deposition of eosinophil granule major basic protein in vernal keratoconjunctivitis and contact lens-associated giant papillary conjunctivitis. Am J Ophthalmol 108:57–63 Udell IJ, Gleich GJ, Allansmith MR, Ackerman SJ, Abelson MB (1981) Eosinophil granule major basic protein and Charcot-Leyden crystal protein in human tears. Am J Ophthalmol 92:824–828 Trocme SD, Kephart GM, Bourne WM, Buckley RJ, Gleich GJ (1993) Eosinophil granule major basic protein deposition in corneal ulcers associated with vernal keratoconjunctivitis. Am J Ophthalmol 115:640–643 Yamamoto N, Tanikawa A, Horiguchi M (2010) Basic study of retinal stem/progenitor cell separation from mouse iris tissue. Med Mol Morphol 43:139–144 McGrogan M, Simonsen C, Scott R, Griffith J, Ellis N, Kennedy J, Campanelli D, Nathan C, Gabay J (1988) Isolation of a complementary DNA clone encoding a precursor to human eosinophil major basic protein. J Exp Med 168:2295–2308 Wasmoen TL, Benirschke K, Gleich GJ (1987) Demonstration of immunoreactive eosinophil granule major basic protein in the plasma and placenta of non-human primates. Placenta 8:283–292 Wasmoen TL, Mckean DJ, Benirschke K, Coulam CB, Gleich GJ (1989) Evidence of eosinophil granule major basic protein in human placenta. J Exp Med 170:2051–2063 Bonno M, Kephart GM, Carlson CM, Loegering DA, Vernof KK, Gleich GJ (1994) Expression of eosinophil-granule major basic protein messenger ribonucleic acid in placenta X cells. Lab Invest 70:234–241 Bonno M, Oxvig C, Kephart GM, Wagner JM, Kristensen T, Sottrup-Jensen L, Gleich GJ (1994) Localization of pregnancy-associated plasma protein-A and colocalization of pregnancy-associated plasma protein-A messenger ribonucleic acid and eosinophil granule major basic protein messenger ribonucleic acid in placenta. Lab Invest 71:560–566 Plager DA, Stuart S, Gleich GJ (1998) Human eosinophil granule major basic protein and its novel homolog. Allergy 53:33–40 Barker RL, Gleich GJ, Pease LR (1988) Acidic precursor revealed in human eosinophil granule major basic protein cDNA. J Exp Med 168:1493–1498 Saeki H, Furue M, Furukawa F, Hide M, Ohtsuki M, Katayama I, Sasaki R, Suto H, Takehara K (2009) Committee for guidelines for the management of atopic dermatitis of Japanese dermatological association. Guidelines for management of atopic dermatitis. J Dermatol 36:563–577 Saeki H, Nakahara T, Tanaka A, Kabashima K, Sugaya M, Murota H, Ebihara T, Kataoka Y, Aihara M, Etoh T, Katoh N (2016) Committee for clinical practice guidelines for the management of atopic dermatitis of japanese dermatological association. Clinical practice guidelines for the management of atopic dermatitis 2016. J Dermatol 43:1117–1145 Katayama I, Aihara M, Ohya Y, Saeki H, Shimojo N, Shoji S, Taniguchi M, Yamada H (2017) Japanese guidelines for atopic dermatitis 2017. Allergol Int 66:230–247 Matsuo T, Saito H, Matsuo N (1997) Cataract and aqueous flare levels in patients with atopic dermatitis. Am J Ophthalmol 124:36–39 Hayashi H, Igarashi C, Hayashi K (2002) Frequency of ciliary body or retinal breaks and retinal detachment in eyes with atopic cataract. Br J Ophthalmol 86:898–901 Iwata S (1974) Process of lens opacification and membrane function: a review. Ophthal Res 6:138–154 Rhodes JD, Sanderson J (2009) The mechanisms of calcium homeostasis and signaling in the lens. Exp Eye Res 88:226–234 Majima K, Majima Y, Kousaka M (1998) Cell-biological analysis of atopic cataractous lenses. Ophthalmologica 212:310–317 Gleich GJ, Adolphson CR (1986) The eosinophilic leukocytestructure and function. Adv Immunol 39:177–253 Abu-Ghazaleh RI, Gleich GJ, Prendergast FG (1992) Interaction of eosinophil granule major basic protein with synthetic lipid bilayers: a mechanism for toxicity. J Membrane Biol 128:153–164 Kolbeck R, Kozhich A, Koike M, Peng L, Andersson CK, Damschroder MM, Reed JL, Woods R, Dall'acqua WW, Stephens GL, Erjefalt JS, Bjermer L, Humbles AA, Gossage D, Wu H, Kiener PA, Spitalny GL, Mackay CR, Molfino NA, Coyle AJ (2010) MEDI-563, a humanized anti-IL-5 receptor alpha mAb with enhanced antibody-dependent cell-mediated cytotoxicity function. J Allergy Clin Immunol 125:1344–1353 Nair P, Wenzel S, Rabe KF, Bourdin A, Lugogo NL, Kuna P, Barker P, Sproule S, Ponnarambil S, Goldman M, Trial Investigators ZONDA (2017) Oral glucocorticoid-sparing effect of benralizumab in severe asthma. N Engl J Med 376:2448–2458